24 / 52
ANALES
OFTALMOLÓGICOS
Tomo VII • Vol. I • N˚1-2-3 · 2015 • Santiago - Chile
Lankenau, Marc Krug, Stefan Oelckers, Ludwig
M. Heindl, UtaGehlsen, GereonHüttmann,
Claus Cursiefen. JAMA Ophthalmol. 2013
September; 131(9): 1135–1142.
10. Split cornea transplantation for 2 recipients
– review of the first 100 consecutive patients.
Ludwig M. Heindl, Stephan Riss, Kathrin
Laaser, Bjoern O. Bachmann, Friedrich E.
Kruse, Claus Cursiefen. Am J Ophthalmol.
2011 October; 152(4): 523–532.e2. Published
online 2011 July 2
11. Immune privilege and immunogenicity resides
among layers of the mouse cornea. J. Hori, N.
C. Joyce, J. W. Streilein. Invest Ophthalmol Vis
Sci. 2000 September; 41(10): 3032–3042.
12. Survival in high-risk eyes of epithelium
deprived orthoptic corneal allografts
reconstituted in vitro with syngeneic
epithelium. Hori J, Streilein JW. Invest
Ophthalmol Vis Sci 2003; 44:658–64.
13. Spontaneus corneal clearence despite graft
detatchment in descemet membrane. Chandra
Balachandran, Lisanne Ham, Christianne A.
Verschoor, T. San Ong, Jacqueline van der
Wees, Gerrit R. J. Melles. Am J Ophthalmol.
2009 August; 148(2): 227–234.e1. Published
online 2009 May 13
14. Patterns of corneal endothelialization and
corneal clearance after Descemet membrane
endothelial keratoplasty for Fuchs endothelial
dystrophy. Dirisamer M, Dapena I, Ham L, et
al. Am J Ophthalmol 2011; 152:543– 555.
15. Descemet membrane endothelial transfer.
Fook Chang Lama,b, Marieke Bruinsmaa,c,
and Gerrit R.J. Mellesa,b. Curr Op Ophtal 2014;
25: 353-328
16. New therapeutic modality for corneal
endotelial disease using rho-associated kinase
inhibitor eye drops. Noriko Koizumi, Naoki
Okumura, Morio Ueno, Shigeru Kinoshita.
Cornea 2014 Nov;33 Suppl 11:S25-31